{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T15:35:35Z","timestamp":1791041735224,"version":"4.1.0"},"reference-count":102,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,5,30]]},"DOI":"10.7759\/cureus.109935","type":"journal-article","created":{"date-parts":[[2026,5,30]],"date-time":"2026-05-30T17:45:11Z","timestamp":1780163111000},"source":"Crossref","is-referenced-by-count":2,"title":["Advanced Glycation End Products and Genetic Polymorphism in the Pathogenesis of Microvascular Complications in Type 2 Diabetes Mellitus: A Narrative Review"],"prefix":"10.7759","author":[{"given":"Rajlaxmi","family":"Sarangi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sweta","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jyoti Prakash","family":"Sahoo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amrita","family":"Satpathy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1055\/a-1624-2897","article-title":"Definition, classification and diagnosis of diabetes mellitus","volume":"130","author":"Schleicher E","year":"2022","unstructured":"Schleicher E, Gerdes C, Petersmann A, et al.. Definition, classification and diagnosis of diabetes mellitus. Exp Clin Endocrinol Diabetes. 2022, 130:S1-8. 10.1055\/a-1624-2897","journal-title":"Exp Clin Endocrinol Diabetes"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.3390\/ijms23042397","article-title":"Diabetes and ischemic stroke: an old and new relationship an overview of the close interaction between these diseases","volume":"23","author":"Maida CD","year":"2022","unstructured":"Maida CD, Daidone M, Pacinella G, Norrito RL, Pinto A, Tuttolomondo A. Diabetes and ischemic stroke: an old and new relationship an overview of the close interaction between these diseases. Int J Mol Sci. 2022, 23:2397. 10.3390\/ijms23042397","journal-title":"Int J Mol Sci"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1111\/obr.13602","article-title":"Microvascular complications of obesity and diabetes-role of bariatric surgery","volume":"24","author":"Bashir B","year":"2023","unstructured":"Bashir B, Iqbal Z, Adam S, et al.. Microvascular complications of obesity and diabetes-role of bariatric surgery. Obes Rev. 2023, 24:e13602. 10.1111\/obr.13602","journal-title":"Obes Rev"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines12091958","article-title":"Management of microcomplications of diabetes mellitus: challenges, current trends, and future perspectives in treatment","volume":"12","author":"Yapislar H","year":"2024","unstructured":"Yapislar H, Gurler EB. Management of microcomplications of diabetes mellitus: challenges, current trends, and future perspectives in treatment. Biomedicines. 2024, 12:1958. 10.3390\/biomedicines12091958","journal-title":"Biomedicines"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1186\/s40001-023-01431-w","article-title":"Role of advanced glycation end products in diabetic vascular injury: molecular mechanisms and therapeutic perspectives","volume":"28","author":"Liu J","year":"2023","unstructured":"Liu J, Pan S, Wang X, Liu Z, Zhang Y. Role of advanced glycation end products in diabetic vascular injury: molecular mechanisms and therapeutic perspectives. Eur J Med Res. 2023, 28:553. 10.1186\/s40001-023-01431-w","journal-title":"Eur J Med Res"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.3390\/cells11081312","article-title":"Advanced glycation end-products (AGEs): formation, chemistry, classification, receptors, and diseases related to AGEs","volume":"11","author":"Twarda-Clapa A","year":"2022","unstructured":"Twarda-Clapa A, Olczak A, Bia\u0142kowska AM, Kozio\u0142kiewicz M. Advanced glycation end-products (AGEs): formation, chemistry, classification, receptors, and diseases related to AGEs. Cells. 2022, 11:1312. 10.3390\/cells11081312","journal-title":"Cells"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.3389\/fmolb.2022.1002710","article-title":"Endogenous advanced glycation end products in the pathogenesis of chronic diabetic complications","volume":"9","author":"Mengstie MA","year":"2022","unstructured":"Mengstie MA, Chekol Abebe E, Behaile Teklemariam A, et al.. Endogenous advanced glycation end products in the pathogenesis of chronic diabetic complications. Front Mol Biosci. 2022, 9:1002710. 10.3389\/fmolb.2022.1002710","journal-title":"Front Mol Biosci"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1007\/s10719-025-10194-x","article-title":"Advanced glycation end products (AGEs) and their role in diabetes mellitus and related complications: mechanisms and therapeutic insights","volume":"42","author":"Qaed E","year":"2025","unstructured":"Qaed E, Aldahmash W, Mahyoub MA. Advanced glycation end products (AGEs) and their role in diabetes mellitus and related complications: mechanisms and therapeutic insights. Glycoconj J. 2025, 42:209-23. 10.1007\/s10719-025-10194-x","journal-title":"Glycoconj J"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.3390\/ijms24129881","article-title":"A role for advanced glycation end products in molecular ageing","volume":"24","author":"Zgutka K","year":"2023","unstructured":"Zgutka K, Tkacz M, Tomasiak P, Tarnowski M. A role for advanced glycation end products in molecular ageing. Int J Mol Sci. 2023, 24:9881. 10.3390\/ijms24129881","journal-title":"Int J Mol Sci"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.3390\/antiox14091044","article-title":"Oxidative stress, advanced glycation end products (AGEs), and neurodegeneration in Alzheimer's disease: a metabolic perspective","volume":"14","author":"Boccardi V","year":"2025","unstructured":"Boccardi V, Mancinetti F, Mecocci P. Oxidative stress, advanced glycation end products (AGEs), and neurodegeneration in Alzheimer's disease: a metabolic perspective. Antioxidants (Basel). 2025, 14:1044. 10.3390\/antiox14091044","journal-title":"Antioxidants (Basel)"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.3390\/ijms25052713","article-title":"The prolonged activation of the p65 subunit of the NF-kappa-B nuclear factor sustains the persistent effect of advanced glycation end products on inflammatory sensitization in macrophages","volume":"25","author":"Assis SI","year":"2024","unstructured":"Assis SI, Amendola LS, Okamoto MM, et al.. The prolonged activation of the p65 subunit of the NF-kappa-B nuclear factor sustains the persistent effect of advanced glycation end products on inflammatory sensitization in macrophages. Int J Mol Sci. 2024, 25:2713. 10.3390\/ijms25052713","journal-title":"Int J Mol Sci"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.2174\/1871527313666140806144831","article-title":"Receptor for AGEs (RAGE) as mediator of NF-kB pathway activation in neuroinflammation and oxidative stress","volume":"13","author":"T\u00f3bon-Velasco JC","year":"2014","unstructured":"T\u00f3bon-Velasco JC, Cuevas E, Torres-Ramos MA. Receptor for AGEs (RAGE) as mediator of NF-kB pathway activation in neuroinflammation and oxidative stress. CNS Neurol Disord Drug Targets. 2014, 13:1615-26. 10.2174\/1871527313666140806144831","journal-title":"CNS Neurol Disord Drug Targets"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1007\/s11033-025-10632-x","article-title":"Mechanism and implications of advanced glycation end products (AGE) and its receptor RAGE axis as crucial mediators linking inflammation and obesity","volume":"52","author":"Kavitha SA","year":"2025","unstructured":"Kavitha SA, Zainab S, Muthyalaiah YS, John CM, Arockiasamy S. Mechanism and implications of advanced glycation end products (AGE) and its receptor RAGE axis as crucial mediators linking inflammation and obesity. Mol Biol Rep. 2025, 52:556. 10.1007\/s11033-025-10632-x","journal-title":"Mol Biol Rep"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2023.1128872","article-title":"RAGE signaling regulates the progression of diabetic complications","volume":"14","author":"Taguchi K","year":"2023","unstructured":"Taguchi K, Fukami K. RAGE signaling regulates the progression of diabetic complications. Front Pharmacol. 2023, 14:1128872. 10.3389\/fphar.2023.1128872","journal-title":"Front Pharmacol"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1007\/s00592-023-02037-8","article-title":"Long-term HbA1c variability and macro-\/micro-vascular complications in type 2 diabetes mellitus: a meta-analysis update","volume":"60","author":"Sartore G","year":"2023","unstructured":"Sartore G, Ragazzi E, Caprino R, Lapolla A. Long-term HbA1c variability and macro-\/micro-vascular complications in type 2 diabetes mellitus: a meta-analysis update. Acta Diabetol. 2023, 60:721-38. 10.1007\/s00592-023-02037-8","journal-title":"Acta Diabetol"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-024-77183-2","article-title":"Diabetic microvascular complications among adults with type 2 diabetes in Adama, Central Ethiopia","volume":"14","author":"Negussie YM","year":"2024","unstructured":"Negussie YM, Sento M, Fati NM. Diabetic microvascular complications among adults with type 2 diabetes in Adama, Central Ethiopia. Sci Rep. 2024, 14:24910. 10.1038\/s41598-024-77183-2","journal-title":"Sci Rep"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000035285","article-title":"Vascular complications of diabetes: a narrative review","volume":"102","author":"Lu Y","year":"2023","unstructured":"Lu Y, Wang W, Liu J, Xie M, Liu Q, Li S. Vascular complications of diabetes: a narrative review. Medicine (Baltimore). 2023, 102:e35285. 10.1097\/MD.0000000000035285","journal-title":"Medicine (Baltimore)"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pgph.0000599","article-title":"Prevalence of microvascular and macrovascular complications of diabetes in newly diagnosed type 2 diabetes in low-and-middle-income countries: a systematic review and meta-analysis","volume":"2","author":"Aikaeli F","year":"2022","unstructured":"Aikaeli F, Njim T, Gissing S, et al.. Prevalence of microvascular and macrovascular complications of diabetes in newly diagnosed type 2 diabetes in low-and-middle-income countries: a systematic review and meta-analysis. PLOS Glob Public Health. 2022, 2:e0000599. 10.1371\/journal.pgph.0000599","journal-title":"PLOS Glob Public Health"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1016\/j.biocel.2015.01.009","article-title":"AGE\/RAGE signalling regulation by miRNAs: associations with diabetic complications and therapeutic potential","volume":"60","author":"Piperi C","year":"2015","unstructured":"Piperi C, Goumenos A, Adamopoulos C, Papavassiliou AG. AGE\/RAGE signalling regulation by miRNAs: associations with diabetic complications and therapeutic potential. Int J Biochem Cell Biol. 2015, 60:197-201. 10.1016\/j.biocel.2015.01.009","journal-title":"Int J Biochem Cell Biol"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.22088\/acadpub.BUMS.6.3.135","article-title":"Polymorphisms of antioxidant' genes as a target for diabetes management","volume":"6","author":"Tabatabaei-Malazy O","year":"2017","unstructured":"Tabatabaei-Malazy O, Khodaeian M, Bitarafan F, Larijani B, Amoli MM. Polymorphisms of antioxidant' genes as a target for diabetes management. Int J Mol Cell Med. 2017, 6:135-47. 10.22088\/acadpub.BUMS.6.3.135","journal-title":"Int J Mol Cell Med"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1186\/s43141-022-00297-5","article-title":"Single nucleotide variants of receptor for advanced glycation end-products (AGER) gene: is it a new opening in the risk assessment of diabetic retinopathy?-a review","volume":"20","author":"Ahuja P","year":"2022","unstructured":"Ahuja P, Waris A, Siddiqui SS, Mukherjee A. Single nucleotide variants of receptor for advanced glycation end-products (AGER) gene: is it a new opening in the risk assessment of diabetic retinopathy?-a review. J Genet Eng Biotechnol. 2022, 20:17. 10.1186\/s43141-022-00297-5","journal-title":"J Genet Eng Biotechnol"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1007\/s11033-025-10846-z","article-title":"The association of RAGE gene polymorphisms with inflammatory and oxidative stress markers in diabetic kidney disease patients","volume":"52","author":"Kamel WA","year":"2025","unstructured":"Kamel WA, Haghi M, Khosroshahi HT, Dehghan G. The association of RAGE gene polymorphisms with inflammatory and oxidative stress markers in diabetic kidney disease patients. Mol Biol Rep. 2025, 52:759. 10.1007\/s11033-025-10846-z","journal-title":"Mol Biol Rep"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1016\/j.diabres.2013.12.004","article-title":"Association of RAGE gene polymorphism with vascular complications in Indian type 2 diabetes mellitus patients","volume":"103","author":"Tripathi AK","year":"2014","unstructured":"Tripathi AK, Chawla D, Bansal S, Banerjee BD, Madhu SV, Kalra OP. Association of RAGE gene polymorphism with vascular complications in Indian type 2 diabetes mellitus patients. Diabetes Res Clin Pract. 2014, 103:474-81. 10.1016\/j.diabres.2013.12.004","journal-title":"Diabetes Res Clin Pract"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1002\/mnfr.200500007","article-title":"Genetic variability in the RAGE gene: possible implications for nutrigenetics, nutrigenomics, and understanding the susceptibility to diabetic complications","volume":"49","author":"Kankov\u00e1 K","year":"2005","unstructured":"Kankov\u00e1 K, Sebekov\u00e1 K. Genetic variability in the RAGE gene: possible implications for nutrigenetics, nutrigenomics, and understanding the susceptibility to diabetic complications. Mol Nutr Food Res. 2005, 49:700-9. 10.1002\/mnfr.200500007","journal-title":"Mol Nutr Food Res"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1038\/s41574-025-01114-y","article-title":"Insulin resistance in type 2 diabetes mellitus","volume":"21","author":"Accili D","year":"2025","unstructured":"Accili D, Deng Z, Liu Q. Insulin resistance in type 2 diabetes mellitus. Nat Rev Endocrinol. 2025, 21:413-26. 10.1038\/s41574-025-01114-y","journal-title":"Nat Rev Endocrinol"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1038\/s41574-022-00746-8","article-title":"The multiple roles of life stress in metabolic disorders","volume":"19","author":"Kivim\u00e4ki M","year":"2023","unstructured":"Kivim\u00e4ki M, Bartolomucci A, Kawachi I. The multiple roles of life stress in metabolic disorders. Nat Rev Endocrinol. 2023, 19:10-27. 10.1038\/s41574-022-00746-8","journal-title":"Nat Rev Endocrinol"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/gfaf177","article-title":"IDF Diabetes Atlas 11th edition 2025: global prevalence and projections for 2050","volume":"41","author":"Duncan BB","year":"2025","unstructured":"Duncan BB, Magliano DJ, Boyko EJ. IDF Diabetes Atlas 11th edition 2025: global prevalence and projections for 2050. Nephrol Dial Transplant. 2025, 41:7-9. 10.1093\/ndt\/gfaf177","journal-title":"Nephrol Dial Transplant"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.45835","article-title":"Cardiovascular complications of diabetes: from microvascular to macrovascular pathways","volume":"15","author":"Zakir M","year":"2023","unstructured":"Zakir M, Ahuja N, Surksha MA, et al.. Cardiovascular complications of diabetes: from microvascular to macrovascular pathways. Cureus. 2023, 15:e45835. 10.7759\/cureus.45835","journal-title":"Cureus"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1007\/s00125-018-4711-2","article-title":"Global trends in diabetes complications: a review of current evidence","volume":"62","author":"Harding JL","year":"2019","unstructured":"Harding JL, Pavkov ME, Magliano DJ, Shaw JE, Gregg EW. Global trends in diabetes complications: a review of current evidence. Diabetologia. 2019, 62:3-16. 10.1007\/s00125-018-4711-2","journal-title":"Diabetologia"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1186\/s12916-022-02675-9","article-title":"Frailty and risk of microvascular complications in patients with type 2 diabetes: a population-based cohort study","volume":"20","author":"Wu Y","year":"2022","unstructured":"Wu Y, Xiong T, Tan X, Chen L. Frailty and risk of microvascular complications in patients with type 2 diabetes: a population-based cohort study. BMC Med. 2022, 20:473. 10.1186\/s12916-022-02675-9","journal-title":"BMC Med"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.3390\/ijms252111850","article-title":"Molecular and cellular mechanisms involved in the pathophysiology of retinal vascular disease-interplay between inflammation and oxidative stress","volume":"25","author":"Srejovic JV","year":"2024","unstructured":"Srejovic JV, Muric MD, Jakovljevic VL, et al.. Molecular and cellular mechanisms involved in the pathophysiology of retinal vascular disease-interplay between inflammation and oxidative stress. Int J Mol Sci. 2024, 25:11850. 10.3390\/ijms252111850","journal-title":"Int J Mol Sci"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.1038\/s41433-025-03901-3","article-title":"Understanding nonproliferative diabetic retinopathy progression using noninvasive imaging","volume":"39","author":"Cunha-Vaz J","year":"2025","unstructured":"Cunha-Vaz J, Mendes L, Reste-Ferreira D. Understanding nonproliferative diabetic retinopathy progression using noninvasive imaging. Eye (Lond). 2025, 39:2627-34. 10.1038\/s41433-025-03901-3","journal-title":"Eye (Lond)"},{"key":"ref33","doi-asserted-by":"publisher","DOI":"10.3390\/life12081202","article-title":"Up-date on diabetic nephropathy","volume":"12","author":"Pelle MC","year":"2022","unstructured":"Pelle MC, Provenzano M, Busutti M, Porcu CV, Zaffina I, Stanga L, Arturi F. Up-date on diabetic nephropathy. Life (Basel). 2022, 12:1202. 10.3390\/life12081202","journal-title":"Life (Basel)"},{"key":"ref34","doi-asserted-by":"publisher","DOI":"10.2337\/dci23-0030","article-title":"Diabetic nephropathy: update on pillars of therapy slowing progression","volume":"46","author":"Naaman SC","year":"2023","unstructured":"Naaman SC, Bakris GL. Diabetic nephropathy: update on pillars of therapy slowing progression. Diabetes Care. 2023, 46:1574-86. 10.2337\/dci23-0030","journal-title":"Diabetes Care"},{"key":"ref35","doi-asserted-by":"publisher","DOI":"10.1038\/ki.1992.118","article-title":"Prevalence and causes of albuminuria in non-insulin-dependent diabetic patients","volume":"41","author":"Parving HH","year":"1992","unstructured":"Parving HH, Gall MA, Sk\u00f8tt P, et al.. Prevalence and causes of albuminuria in non-insulin-dependent diabetic patients. Kidney Int. 1992, 41:758-62. 10.1038\/ki.1992.118","journal-title":"Kidney Int"},{"key":"ref36","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-025-02175-1","article-title":"Diabetic neuropathy: cutting-edge research and future directions","volume":"10","author":"Yang Y","year":"2025","unstructured":"Yang Y, Zhao B, Wang Y, Lan H, Liu X, Hu Y, Cao P. Diabetic neuropathy: cutting-edge research and future directions. Signal Transduct Target Ther. 2025, 10:132. 10.1038\/s41392-025-02175-1","journal-title":"Signal Transduct Target Ther"},{"key":"ref37","doi-asserted-by":"publisher","DOI":"10.1007\/s11916-024-01243-5","article-title":"Diabetic neuropathy: pathophysiology review","volume":"28","author":"Strand N","year":"2024","unstructured":"Strand N, Anderson MA, Attanti S, et al.. Diabetic neuropathy: pathophysiology review. Curr Pain Headache Rep. 2024, 28:481-7. 10.1007\/s11916-024-01243-5","journal-title":"Curr Pain Headache Rep"},{"key":"ref38","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2023.1265372","article-title":"Diabetic peripheral neuropathy: pathogenetic mechanisms and treatment","volume":"14","author":"Zhu J","year":"2023","unstructured":"Zhu J, Hu Z, Luo Y, et al.. Diabetic peripheral neuropathy: pathogenetic mechanisms and treatment. Front Endocrinol (Lausanne). 2023, 14:1265372. 10.3389\/fendo.2023.1265372","journal-title":"Front Endocrinol (Lausanne)"},{"key":"ref39","doi-asserted-by":"publisher","DOI":"10.3389\/fphys.2018.00896","article-title":"Sources of inter-individual variability in the therapeutic response of blood glucose control to exercise in type 2 diabetes: going beyond exercise dose","volume":"9","author":"Solomon TP","year":"2018","unstructured":"Solomon TP. Sources of inter-individual variability in the therapeutic response of blood glucose control to exercise in type 2 diabetes: going beyond exercise dose. Front Physiol. 2018, 9:896. 10.3389\/fphys.2018.00896","journal-title":"Front Physiol"},{"key":"ref40","doi-asserted-by":"publisher","DOI":"10.1186\/s10020-024-00905-9","article-title":"Advanced glycation end products and reactive oxygen species: uncovering the potential role of ferroptosis in diabetic complications","volume":"30","author":"Chen Y","year":"2024","unstructured":"Chen Y, Meng Z, Li Y, Liu S, Hu P, Luo E. Advanced glycation end products and reactive oxygen species: uncovering the potential role of ferroptosis in diabetic complications. Mol Med. 2024, 30:141. 10.1186\/s10020-024-00905-9","journal-title":"Mol Med"},{"key":"ref41","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines12040747","article-title":"Aldose reductase as a key target in the prevention and treatment of diabetic retinopathy: a comprehensive review","volume":"12","author":"D\u0103nil\u0103 AI","year":"2024","unstructured":"D\u0103nil\u0103 AI, Ghenciu LA, Stoicescu ER, Bolintineanu SL, Iacob R, S\u0103ndesc MA, Faur AC. Aldose reductase as a key target in the prevention and treatment of diabetic retinopathy: a comprehensive review. Biomedicines. 2024, 12:747. 10.3390\/biomedicines12040747","journal-title":"Biomedicines"},{"key":"ref42","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pbio.3001678","article-title":"The polyol pathway is an evolutionarily conserved system for sensing glucose uptake","volume":"20","author":"Sano H","year":"2022","unstructured":"Sano H, Nakamura A, Yamane M, et al.. The polyol pathway is an evolutionarily conserved system for sensing glucose uptake. PLoS Biol. 2022, 20:e3001678. 10.1371\/journal.pbio.3001678","journal-title":"PLoS Biol"},{"key":"ref43","doi-asserted-by":"publisher","DOI":"10.2174\/1871527320666210825112240","article-title":"The role of biofactors in diabetic microvascular complications","volume":"18","author":"Ziegler D","year":"2022","unstructured":"Ziegler D, Porta M, Papanas N, et al.. The role of biofactors in diabetic microvascular complications. Curr Diabetes Rev. 2022, 18:e250821195830. 10.2174\/1871527320666210825112240","journal-title":"Curr Diabetes Rev"},{"key":"ref44","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2022.973058","article-title":"The role of protein kinase C in diabetic microvascular complications","volume":"13","author":"Pan D","year":"2022","unstructured":"Pan D, Xu L, Guo M. The role of protein kinase C in diabetic microvascular complications. Front Endocrinol (Lausanne). 2022, 13:973058. 10.3389\/fendo.2022.973058","journal-title":"Front Endocrinol (Lausanne)"},{"key":"ref45","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2024.1359255","article-title":"Endothelial dysfunction in vascular complications of diabetes: a comprehensive review of mechanisms and implications","volume":"15","author":"Yang DR","year":"2024","unstructured":"Yang DR, Wang MY, Zhang CL, Wang Y. Endothelial dysfunction in vascular complications of diabetes: a comprehensive review of mechanisms and implications. Front Endocrinol (Lausanne). 2024, 15:1359255. 10.3389\/fendo.2024.1359255","journal-title":"Front Endocrinol (Lausanne)"},{"key":"ref46","doi-asserted-by":"publisher","DOI":"10.3390\/nu14153086","article-title":"Advanced glycation end products and their effect on vascular complications in type 2 diabetes mellitus","volume":"14","author":"Lee J","year":"2022","unstructured":"Lee J, Yun JS, Ko SH. Advanced glycation end products and their effect on vascular complications in type 2 diabetes mellitus. Nutrients. 2022, 14:3086. 10.3390\/nu14153086","journal-title":"Nutrients"},{"key":"ref47","doi-asserted-by":"publisher","DOI":"10.3390\/biom12040542","article-title":"Advanced glycation end products and diabetes mellitus: mechanisms and perspectives","volume":"12","author":"Khalid M","year":"2022","unstructured":"Khalid M, Petroianu G, Adem A. Advanced glycation end products and diabetes mellitus: mechanisms and perspectives. Biomolecules. 2022, 12:542. 10.3390\/biom12040542","journal-title":"Biomolecules"},{"key":"ref48","doi-asserted-by":"publisher","DOI":"10.3389\/fpubh.2023.1253506","article-title":"Metabolic diseases and healthy aging: identifying environmental and behavioral risk factors and promoting public health","volume":"11","author":"Zhang K","year":"2023","unstructured":"Zhang K, Ma Y, Luo Y, et al.. Metabolic diseases and healthy aging: identifying environmental and behavioral risk factors and promoting public health. Front Public Health. 2023, 11:1253506. 10.3389\/fpubh.2023.1253506","journal-title":"Front Public Health"},{"key":"ref49","doi-asserted-by":"publisher","DOI":"10.1016\/j.jdiacomp.2022.108354","article-title":"Inflammation level in type 2 diabetes is associated with dietary advanced glycation end products, Mediterranean diet adherence and oxidative balance score: a pathway analysis","volume":"37","author":"Demirer B","year":"2023","unstructured":"Demirer B, Yard\u0131mc\u0131 H, Erem Basmaz S. Inflammation level in type 2 diabetes is associated with dietary advanced glycation end products, Mediterranean diet adherence and oxidative balance score: a pathway analysis. J Diabetes Complications. 2023, 37:108354. 10.1016\/j.jdiacomp.2022.108354","journal-title":"J Diabetes Complications"},{"key":"ref50","doi-asserted-by":"publisher","DOI":"10.3390\/nu14132675","article-title":"Advanced glycation end products (AGEs) and chronic kidney disease: does the modern diet AGE the kidney?","volume":"14","author":"Fotheringham AK","year":"2022","unstructured":"Fotheringham AK, Gallo LA, Borg DJ, Forbes JM. Advanced glycation end products (AGEs) and chronic kidney disease: does the modern diet AGE the kidney?. Nutrients. 2022, 14:2675. 10.3390\/nu14132675","journal-title":"Nutrients"},{"key":"ref51","doi-asserted-by":"publisher","DOI":"10.3390\/ijms26157311","article-title":"The role of advanced glycation end-products in the pathophysiology and pharmacotherapy of cardiovascular disease","volume":"26","author":"Mota KO","year":"2025","unstructured":"Mota KO, de Vasconcelos CM, Kirshenbaum LA, Dhalla NS. The role of advanced glycation end-products in the pathophysiology and pharmacotherapy of cardiovascular disease. Int J Mol Sci. 2025, 26:7311. 10.3390\/ijms26157311","journal-title":"Int J Mol Sci"},{"key":"ref52","doi-asserted-by":"publisher","DOI":"10.1016\/j.metabol.2017.03.004","article-title":"A quick, simple method for detecting circulating fluorescent advanced glycation end-products: correlation with in vitro and in vivo non-enzymatic glycation","volume":"71","author":"Villa M","year":"2017","unstructured":"Villa M, Parravano M, Micheli A, et al.. A quick, simple method for detecting circulating fluorescent advanced glycation end-products: correlation with in vitro and in vivo non-enzymatic glycation. Metabolism. 2017, 71:64-9. 10.1016\/j.metabol.2017.03.004","journal-title":"Metabolism"},{"key":"ref53","doi-asserted-by":"publisher","DOI":"10.4239\/wjd.v14.i7.995","article-title":"Advanced glycation end product signaling and metabolic complications: dietary approach","volume":"14","author":"Khan MI","year":"2023","unstructured":"Khan MI, Ashfaq F, Alsayegh AA, et al.. Advanced glycation end product signaling and metabolic complications: dietary approach. World J Diabetes. 2023, 14:995-1012. 10.4239\/wjd.v14.i7.995","journal-title":"World J Diabetes"},{"key":"ref54","doi-asserted-by":"publisher","DOI":"10.1186\/s12967-023-04315-z","article-title":"Impaired angiogenesis in ageing: the central role of the extracellular matrix","volume":"21","author":"Xiao P","year":"2023","unstructured":"Xiao P, Zhang Y, Zeng Y, et al.. Impaired angiogenesis in ageing: the central role of the extracellular matrix. J Transl Med. 2023, 21:457. 10.1186\/s12967-023-04315-z","journal-title":"J Transl Med"},{"key":"ref55","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1257988","article-title":"Research progress of NF-\u03baB signaling pathway and thrombosis","volume":"14","author":"Wang Z","year":"2023","unstructured":"Wang Z, Fang C, Yao M, Wu D, Chen M, Guo T, Mo J. Research progress of NF-\u03baB signaling pathway and thrombosis. Front Immunol. 2023, 14:1257988. 10.3389\/fimmu.2023.1257988","journal-title":"Front Immunol"},{"key":"ref56","doi-asserted-by":"publisher","DOI":"10.1161\/01.atv.20.11.e83","article-title":"The transcription factor NF-kappa B and the regulation of vascular cell function","volume":"20","author":"De Martin R","year":"2000","unstructured":"De Martin R, Hoeth M, Hofer-Warbinek R, Schmid JA. The transcription factor NF-kappa B and the regulation of vascular cell function. Arterioscler Thromb Vasc Biol. 2000, 20:E83-8. 10.1161\/01.atv.20.11.e83","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"ref57","doi-asserted-by":"publisher","DOI":"10.1089\/ars.2009.2484","article-title":"Hyperglycemia and glycation in diabetic complications","volume":"11","author":"Negre-Salvayre A","year":"2009","unstructured":"Negre-Salvayre A, Salvayre R, Aug\u00e9 N, Pamplona R, Portero-Ot\u00edn M. Hyperglycemia and glycation in diabetic complications. Antioxid Redox Signal. 2009, 11:3071-109. 10.1089\/ars.2009.2484","journal-title":"Antioxid Redox Signal"},{"key":"ref58","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202510242","article-title":"Modulation of aging diseases via RAGE targets: a dietary intervention review","volume":"12","author":"Wu Q","year":"2025","unstructured":"Wu Q, Yan J, Zhang Y, et al.. Modulation of aging diseases via RAGE targets: a dietary intervention review. Adv Sci (Weinh). 2025, 12:e10242. 10.1002\/advs.202510242","journal-title":"Adv Sci (Weinh)"},{"key":"ref59","doi-asserted-by":"publisher","DOI":"10.1007\/s11033-026-11605-4","article-title":"Mechanistic insights into the role of salicin in mitigating oxidative and inflammatory pathways of diabetic complications","volume":"53","author":"Ahmed MS","year":"2026","unstructured":"Ahmed MS, Manirujjaman M. Mechanistic insights into the role of salicin in mitigating oxidative and inflammatory pathways of diabetic complications. Mol Biol Rep. 2026, 53:420. 10.1007\/s11033-026-11605-4","journal-title":"Mol Biol Rep"},{"key":"ref60","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2024.107282","article-title":"Activation and modulation of the AGEs-RAGE axis: implications for inflammatory pathologies and therapeutic interventions - a review","volume":"206","author":"Zhou M","year":"2024","unstructured":"Zhou M, Zhang Y, Shi L, Li L, Zhang D, Gong Z, Wu Q. Activation and modulation of the AGEs-RAGE axis: implications for inflammatory pathologies and therapeutic interventions - a review. Pharmacol Res. 2024, 206:107282. 10.1016\/j.phrs.2024.107282","journal-title":"Pharmacol Res"},{"key":"ref61","doi-asserted-by":"publisher","DOI":"10.3390\/ijms26083707","article-title":"The advanced glycation end-products (AGE)-receptor for AGE system (RAGE): an inflammatory pathway linking obesity and cardiovascular diseases","volume":"26","author":"Vianello E","year":"2025","unstructured":"Vianello E, Beltrami AP, Aleksova A, et al.. The advanced glycation end-products (AGE)-receptor for AGE system (RAGE): an inflammatory pathway linking obesity and cardiovascular diseases. Int J Mol Sci. 2025, 26:3707. 10.3390\/ijms26083707","journal-title":"Int J Mol Sci"},{"key":"ref62","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.931473","article-title":"Pathophysiology of RAGE in inflammatory diseases","volume":"13","author":"Dong H","year":"2022","unstructured":"Dong H, Zhang Y, Huang Y, Deng H. Pathophysiology of RAGE in inflammatory diseases. Front Immunol. 2022, 13:931473. 10.3389\/fimmu.2022.931473","journal-title":"Front Immunol"},{"key":"ref63","doi-asserted-by":"publisher","DOI":"10.4196\/kjpp.2014.18.1.1","article-title":"Advanced glycation end products and diabetic complications","volume":"18","author":"Singh VP","year":"2014","unstructured":"Singh VP, Bali A, Singh N, Jaggi AS. Advanced glycation end products and diabetic complications. Korean J Physiol Pharmacol. 2014, 18:1-14. 10.4196\/kjpp.2014.18.1.1","journal-title":"Korean J Physiol Pharmacol"},{"key":"ref64","doi-asserted-by":"publisher","DOI":"10.1186\/s13098-022-00873-2","article-title":"Advanced glycation end products and diabetes and other metabolic indicators","volume":"14","author":"Jiang T","year":"2022","unstructured":"Jiang T, Zhang Y, Dai F, Liu C, Hu H, Zhang Q. Advanced glycation end products and diabetes and other metabolic indicators. Diabetol Metab Syndr. 2022, 14:104. 10.1186\/s13098-022-00873-2","journal-title":"Diabetol Metab Syndr"},{"key":"ref65","doi-asserted-by":"publisher","DOI":"10.4239\/wjd.v14.i8.1146","article-title":"Advanced glycation end products: key mediator and therapeutic target of cardiovascular complications in diabetes","volume":"14","author":"Bansal S","year":"2023","unstructured":"Bansal S, Burman A, Tripathi AK. Advanced glycation end products: key mediator and therapeutic target of cardiovascular complications in diabetes. World J Diabetes. 2023, 14:1146-62. 10.4239\/wjd.v14.i8.1146","journal-title":"World J Diabetes"},{"key":"ref66","doi-asserted-by":"publisher","DOI":"10.1186\/s13098-025-01748-y","article-title":"Genetics of diabetes and its complications: a comprehensive review","volume":"17","author":"Sami A","year":"2025","unstructured":"Sami A, Javed A, Ozsahin DU, Ozsahin I, Muhammad K, Waheed Y. Genetics of diabetes and its complications: a comprehensive review. Diabetol Metab Syndr. 2025, 17:185. 10.1186\/s13098-025-01748-y","journal-title":"Diabetol Metab Syndr"},{"key":"ref67","doi-asserted-by":"publisher","DOI":"10.1002\/edm2.70204","article-title":"Implications of genetic elements on type 2 diabetes mellitus pathogenesis and management","volume":"9","author":"Ngcobo NN","year":"2026","unstructured":"Ngcobo NN, Sibiya NH. Implications of genetic elements on type 2 diabetes mellitus pathogenesis and management. Endocrinol Diabetes Metab. 2026, 9:e70204. 10.1002\/edm2.70204","journal-title":"Endocrinol Diabetes Metab"},{"key":"ref68","doi-asserted-by":"publisher","DOI":"10.4239\/wjd.v14.i6.656","article-title":"Genetics of diabetes","volume":"14","author":"Goyal S","year":"2023","unstructured":"Goyal S, Rani J, Bhat MA, Vanita V. Genetics of diabetes. World J Diabetes. 2023, 14:656-79. 10.4239\/wjd.v14.i6.656","journal-title":"World J Diabetes"},{"key":"ref69","doi-asserted-by":"publisher","DOI":"10.1016\/j.jceh.2026.103530","article-title":"The association between genetic polymorphism in the receptor for advanced glycation end-products and metabolic dysfunction-associated steatotic liver disease","volume":"16","author":"Mohammed N","year":"2026","unstructured":"Mohammed N, Hassouna MM, Mostafa MS, Elashkar AE, Abdelsameea E, Naguib MA. The association between genetic polymorphism in the receptor for advanced glycation end-products and metabolic dysfunction-associated steatotic liver disease. J Clin Exp Hepatol. 2026, 16:103530. 10.1016\/j.jceh.2026.103530","journal-title":"J Clin Exp Hepatol"},{"key":"ref70","doi-asserted-by":"publisher","DOI":"10.1007\/s13205-025-04652-4","article-title":"The intricacies of advanced glycation end products (AGEs) in diabetic neuropathy","volume":"16","author":"Rao W","year":"2026","unstructured":"Rao W, Hussain M, Naseem N, Siddiqui WA. The intricacies of advanced glycation end products (AGEs) in diabetic neuropathy. 3 Biotech. 2026, 16:24. 10.1007\/s13205-025-04652-4","journal-title":"3 Biotech"},{"key":"ref71","doi-asserted-by":"publisher","DOI":"10.3390\/microorganisms10091848","article-title":"Advanced glycation end products in health and disease","volume":"10","author":"Reddy VP","year":"2022","unstructured":"Reddy VP, Aryal P, Darkwah EK. Advanced glycation end products in health and disease. Microorganisms. 2022, 10:1848. 10.3390\/microorganisms10091848","journal-title":"Microorganisms"},{"key":"ref72","doi-asserted-by":"publisher","DOI":"10.3390\/microorganisms13122778","article-title":"Bacterial adaptation to stress induced by glyoxal\/methylglyoxal and advanced glycation end products","volume":"13","author":"Kuczy\u0144ska-Wi\u015bnik D","year":"2025","unstructured":"Kuczy\u0144ska-Wi\u015bnik D, Stojowska-Sw\u0119drzy\u0144ska K, Laskowska E. Bacterial adaptation to stress induced by glyoxal\/methylglyoxal and advanced glycation end products. Microorganisms. 2025, 13:2778. 10.3390\/microorganisms13122778","journal-title":"Microorganisms"},{"key":"ref73","doi-asserted-by":"publisher","DOI":"10.1186\/s12931-024-03014-7","article-title":"Serum soluble isoform of receptor for advanced glycation end product is a predictive biomarker for acute exacerbation of idiopathic pulmonary fibrosis: a German and Japanese cohort study","volume":"25","author":"Kitadai E","year":"2024","unstructured":"Kitadai E, Yamaguchi K, Ohshimo S, et al.. Serum soluble isoform of receptor for advanced glycation end product is a predictive biomarker for acute exacerbation of idiopathic pulmonary fibrosis: a German and Japanese cohort study. Respir Res. 2024, 25:405. 10.1186\/s12931-024-03014-7","journal-title":"Respir Res"},{"key":"ref74","doi-asserted-by":"publisher","DOI":"10.3390\/antiox11071253","article-title":"In patients with chronic kidney disease advanced glycation end-products receptors isoforms (sRAGE and esRAGE) are associated with malnutrition","volume":"11","author":"Caldiroli L","year":"2022","unstructured":"Caldiroli L, Molinari P, Dozio E, et al.. In patients with chronic kidney disease advanced glycation end-products receptors isoforms (sRAGE and esRAGE) are associated with malnutrition. Antioxidants (Basel). 2022, 11:1253. 10.3390\/antiox11071253","journal-title":"Antioxidants (Basel)"},{"key":"ref75","doi-asserted-by":"publisher","DOI":"10.1002\/wnan.1935","article-title":"Receptor for advanced glycation end-products: biological significance and imaging applications","volume":"16","author":"Dobrucki IT","year":"2024","unstructured":"Dobrucki IT, Miskalis A, Nelappana M, et al.. Receptor for advanced glycation end-products: biological significance and imaging applications. Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2024, 16:e1935. 10.1002\/wnan.1935","journal-title":"Wiley Interdiscip Rev Nanomed Nanobiotechnol"},{"key":"ref76","doi-asserted-by":"publisher","DOI":"10.3390\/ijms24032894","article-title":"The potential influence of advanced glycation end products and (s)RAGE in rheumatic diseases","volume":"24","author":"Delrue C","year":"2023","unstructured":"Delrue C, Speeckaert R, Delanghe JR, Speeckaert MM. The potential influence of advanced glycation end products and (s)RAGE in rheumatic diseases. Int J Mol Sci. 2023, 24:2894. 10.3390\/ijms24032894","journal-title":"Int J Mol Sci"},{"key":"ref77","doi-asserted-by":"publisher","DOI":"10.1042\/CS20080494","article-title":"RAGE: a novel biological and genetic marker for vascular disease","volume":"116","author":"Kalea AZ","year":"2009","unstructured":"Kalea AZ, Schmidt AM, Hudson BI. RAGE: a novel biological and genetic marker for vascular disease. Clin Sci (Lond). 2009, 116:621-37. 10.1042\/CS20080494","journal-title":"Clin Sci (Lond)"},{"key":"ref78","doi-asserted-by":"publisher","DOI":"10.1155\/2019\/2067353","article-title":"Pathological implications of receptor for advanced glycation end-product (AGER) gene polymorphism","volume":"2019","author":"Serveaux-Dancer M","year":"2019","unstructured":"Serveaux-Dancer M, Jabaudon M, Creveaux I, et al.. Pathological implications of receptor for advanced glycation end-product (AGER) gene polymorphism. Dis Markers. 2019, 2019:2067353. 10.1155\/2019\/2067353","journal-title":"Dis Markers"},{"key":"ref79","doi-asserted-by":"publisher","DOI":"10.1111\/cge.12800","article-title":"The promoter polymorphisms of receptor for advanced glycation end products were associated with the susceptibility and progression of sepsis","volume":"91","author":"Shao Y","year":"2017","unstructured":"Shao Y, Shao X, He J, et al.. The promoter polymorphisms of receptor for advanced glycation end products were associated with the susceptibility and progression of sepsis. Clin Genet. 2017, 91:564-75. 10.1111\/cge.12800","journal-title":"Clin Genet"},{"key":"ref80","doi-asserted-by":"publisher","DOI":"10.1183\/23120541.00947-2020","article-title":"Single-nucleotide polymorphism rs2070600 regulates AGER splicing and the sputum levels of the COPD biomarker soluble receptor for advanced glycation end-products","volume":"7","author":"Faiz A","year":"2021","unstructured":"Faiz A, Rathnayake SN, Ten Hacken NH, Guryev V, van den Berge M, Pouwels SD. Single-nucleotide polymorphism rs2070600 regulates AGER splicing and the sputum levels of the COPD biomarker soluble receptor for advanced glycation end-products. ERJ Open Res. 2021, 7:00947-2020. 10.1183\/23120541.00947-2020","journal-title":"ERJ Open Res"},{"key":"ref81","doi-asserted-by":"publisher","DOI":"10.1080\/10408363.2020.1791045","article-title":"The role of soluble receptor for advanced glycation end-products (sRAGE) in the general population and patients with diabetes mellitus with a focus on renal function and overall outcome","volume":"58","author":"Steenbeke M","year":"2021","unstructured":"Steenbeke M, De Bruyne S, De Buyzere M, et al.. The role of soluble receptor for advanced glycation end-products (sRAGE) in the general population and patients with diabetes mellitus with a focus on renal function and overall outcome. Crit Rev Clin Lab Sci. 2021, 58:113-30. 10.1080\/10408363.2020.1791045","journal-title":"Crit Rev Clin Lab Sci"},{"key":"ref82","doi-asserted-by":"publisher","DOI":"10.1186\/s12920-025-02215-3","article-title":"Advanced glycation end-product receptor gene (RAGE) polymorphisms in patients with acute coronary syndrome - a case-control study in the Polish population","volume":"18","author":"Gutowska K","year":"2025","unstructured":"Gutowska K, Ambroziak M, Podraza J, Puzianowska-Ku\u017anicka M, Czajkowski K, Budaj A, Kury\u0142owicz A. Advanced glycation end-product receptor gene (RAGE) polymorphisms in patients with acute coronary syndrome - a case-control study in the Polish population. BMC Med Genomics. 2025, 18:143. 10.1186\/s12920-025-02215-3","journal-title":"BMC Med Genomics"},{"key":"ref83","doi-asserted-by":"publisher","DOI":"10.1155\/2013\/264579","article-title":"Association of the receptor for advanced glycation end products gene polymorphisms and circulating RAGE levels with diabetic retinopathy in the Chinese population","volume":"2013","author":"Yang L","year":"2013","unstructured":"Yang L, Wu Q, Li Y, et al.. Association of the receptor for advanced glycation end products gene polymorphisms and circulating RAGE levels with diabetic retinopathy in the Chinese population. J Diabetes Res. 2013, 2013:264579. 10.1155\/2013\/264579","journal-title":"J Diabetes Res"},{"key":"ref84","doi-asserted-by":"publisher","DOI":"10.1007\/s12013-025-01888-y","article-title":"Unraveling the systems biology of curcumin: a mini-review of its anti-diabetic potential through network pharmacology","volume":"84","author":"Roney M","year":"2026","unstructured":"Roney M, Mohd Aluwi MF. Unraveling the systems biology of curcumin: a mini-review of its anti-diabetic potential through network pharmacology. Cell Biochem Biophys. 2026, 84:107-29. 10.1007\/s12013-025-01888-y","journal-title":"Cell Biochem Biophys"},{"key":"ref85","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0128452","article-title":"Genetics of plasma soluble receptor for advanced glycation end-products and cardiovascular outcomes in a community-based population: results from the atherosclerosis risk in communities study","volume":"10","author":"Maruthur NM","year":"2015","unstructured":"Maruthur NM, Li M, Halushka MK, et al.. Genetics of plasma soluble receptor for advanced glycation end-products and cardiovascular outcomes in a community-based population: results from the atherosclerosis risk in communities study. PLoS One. 2015, 10:e0128452. 10.1371\/journal.pone.0128452","journal-title":"PLoS One"},{"key":"ref86","doi-asserted-by":"publisher","DOI":"10.3390\/antiox14080956","article-title":"Glyoxalase 1 inducer, trans-resveratrol and hesperetin-dietary supplement with multi-modal health benefits","volume":"14","author":"Xue M","year":"2025","unstructured":"Xue M, Rabbani N, Thornalley PJ. Glyoxalase 1 inducer, trans-resveratrol and hesperetin-dietary supplement with multi-modal health benefits. Antioxidants (Basel). 2025, 14:956. 10.3390\/antiox14080956","journal-title":"Antioxidants (Basel)"},{"key":"ref87","doi-asserted-by":"publisher","DOI":"10.3390\/antiox12091663","article-title":"Molecular link between Glo-1 expression and markers of hyperglycemia and oxidative stress in vascular complications of type 2 diabetes mellitus","volume":"12","author":"Syed NA","year":"2023","unstructured":"Syed NA, Bhatti A, John P. Molecular link between Glo-1 expression and markers of hyperglycemia and oxidative stress in vascular complications of type 2 diabetes mellitus. Antioxidants (Basel). 2023, 12:1663. 10.3390\/antiox12091663","journal-title":"Antioxidants (Basel)"},{"key":"ref88","doi-asserted-by":"publisher","DOI":"10.1089\/ars.2017.7424","article-title":"Glyoxalase 1 modulation in obesity and diabetes","volume":"30","author":"Rabbani N","year":"2019","unstructured":"Rabbani N, Thornalley PJ. Glyoxalase 1 modulation in obesity and diabetes. Antioxid Redox Signal. 2019, 30:354-74. 10.1089\/ars.2017.7424","journal-title":"Antioxid Redox Signal"},{"key":"ref89","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-020-69184-8","article-title":"The Gly82Ser mutation in AGER contributes to pathogenesis of pulmonary fibrosis in combined pulmonary fibrosis and emphysema (CPFE) in Japanese patients","volume":"10","author":"Kinjo T","year":"2020","unstructured":"Kinjo T, Kitaguchi Y, Droma Y, et al.. The Gly82Ser mutation in AGER contributes to pathogenesis of pulmonary fibrosis in combined pulmonary fibrosis and emphysema (CPFE) in Japanese patients. Sci Rep. 2020, 10:12811. 10.1038\/s41598-020-69184-8","journal-title":"Sci Rep"},{"key":"ref90","doi-asserted-by":"publisher","DOI":"10.1155\/2019\/8562408","article-title":"Oxidative stress as the main target in diabetic retinopathy pathophysiology","volume":"2019","author":"Cecilia OM","year":"2019","unstructured":"Cecilia OM, Jos\u00e9 Alberto CG, Jos\u00e9 NP, et al.. Oxidative stress as the main target in diabetic retinopathy pathophysiology. J Diabetes Res. 2019, 2019:8562408. 10.1155\/2019\/8562408","journal-title":"J Diabetes Res"},{"key":"ref91","doi-asserted-by":"publisher","DOI":"10.3390\/antiox13030277","article-title":"Genetic and transcriptomic background of oxidative stress and antioxidative therapies in late complications of type 2 diabetes mellitus: a systematic review","volume":"13","author":"Tonin G","year":"2024","unstructured":"Tonin G, Dol\u017ean V, Klen J. Genetic and transcriptomic background of oxidative stress and antioxidative therapies in late complications of type 2 diabetes mellitus: a systematic review. Antioxidants (Basel). 2024, 13:277. 10.3390\/antiox13030277","journal-title":"Antioxidants (Basel)"},{"key":"ref92","doi-asserted-by":"publisher","DOI":"10.3390\/metabo15070479","article-title":"The complexity of oxidative stress in human age-related diseases-a review","volume":"15","author":"P\u0142\u00f3ciniczak A","year":"2025","unstructured":"P\u0142\u00f3ciniczak A, Bukowska-Olech E, Wysocka E. The complexity of oxidative stress in human age-related diseases-a review. Metabolites. 2025, 15:479. 10.3390\/metabo15070479","journal-title":"Metabolites"},{"key":"ref93","doi-asserted-by":"publisher","DOI":"10.3390\/cimb47080614","article-title":"Oxidative-inflammatory crosstalk and multi-target natural agents: decoding diabetic vascular complications","volume":"47","author":"Liu J","year":"2025","unstructured":"Liu J, Li K, Yi Z, Saqirile, Wang C, Yang R. Oxidative-inflammatory crosstalk and multi-target natural agents: decoding diabetic vascular complications. Curr Issues Mol Biol. 2025, 47:614. 10.3390\/cimb47080614","journal-title":"Curr Issues Mol Biol"},{"key":"ref94","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2025.1509884","article-title":"Comprehensive treatment of diabetic endothelial dysfunction based on pathophysiological mechanism","volume":"12","author":"Liu Z","year":"2025","unstructured":"Liu Z, Lu J, Sha W, Lei T. Comprehensive treatment of diabetic endothelial dysfunction based on pathophysiological mechanism. Front Med (Lausanne). 2025, 12:1509884. 10.3389\/fmed.2025.1509884","journal-title":"Front Med (Lausanne)"},{"key":"ref95","doi-asserted-by":"publisher","DOI":"10.3390\/biom12111712","article-title":"Receptor for advanced glycation end product, organ crosstalk, and pathomechanism targets for comprehensive molecular therapeutics in diabetic ischemic stroke","volume":"12","author":"Rao NL","year":"2022","unstructured":"Rao NL, Kotian GB, Shetty JK, et al.. Receptor for advanced glycation end product, organ crosstalk, and pathomechanism targets for comprehensive molecular therapeutics in diabetic ischemic stroke. Biomolecules. 2022, 12:1712. 10.3390\/biom12111712","journal-title":"Biomolecules"},{"key":"ref96","doi-asserted-by":"publisher","DOI":"10.1186\/s12902-025-01897-1","article-title":"Polymorphic variants and risk of diabetic peripheral neuropathy in patients with type 2 diabetes mellitus: systematic review and meta-analysis","volume":"25","author":"Vinelli-Arzubiaga D","year":"2025","unstructured":"Vinelli-Arzubiaga D, Suasnabar Campos CE, Laso-Salazar MC, Abarca-Barriga H. Polymorphic variants and risk of diabetic peripheral neuropathy in patients with type 2 diabetes mellitus: systematic review and meta-analysis. BMC Endocr Disord. 2025, 25:69. 10.1186\/s12902-025-01897-1","journal-title":"BMC Endocr Disord"},{"key":"ref97","doi-asserted-by":"publisher","DOI":"10.1002\/edm2.70122","article-title":"Association of the endothelial nitric oxide synthase (eNOS) G894T gene polymorphism with type 2 diabetes mellitus in a Tunisian population","volume":"9","author":"Ba A","year":"2026","unstructured":"Ba A, Ayoub M, Aboulkacem S, Belhedi M, Aouni Z, Mazigh C. Association of the endothelial nitric oxide synthase (eNOS) G894T gene polymorphism with type 2 diabetes mellitus in a Tunisian population. Endocrinol Diabetes Metab. 2026, 9:e70122. 10.1002\/edm2.70122","journal-title":"Endocrinol Diabetes Metab"},{"key":"ref98","doi-asserted-by":"publisher","DOI":"10.1186\/s13098-024-01473-y","article-title":"New insights on genetic background of major diabetic vascular complications","volume":"16","author":"Tariq Z","year":"2024","unstructured":"Tariq Z, Abusnana S, Mussa BM, Zakaria H. New insights on genetic background of major diabetic vascular complications. Diabetol Metab Syndr. 2024, 16:243. 10.1186\/s13098-024-01473-y","journal-title":"Diabetol Metab Syndr"},{"key":"ref99","doi-asserted-by":"publisher","DOI":"10.3390\/antiox12030584","article-title":"Accelerated AGEing: the impact of advanced glycation end products on the prognosis of chronic kidney disease","volume":"12","author":"Dozio E","year":"2023","unstructured":"Dozio E, Caldiroli L, Molinari P, Castellano G, Delfrate NW, Romanelli MM, Vettoretti S. Accelerated AGEing: the impact of advanced glycation end products on the prognosis of chronic kidney disease. Antioxidants (Basel). 2023, 12:584. 10.3390\/antiox12030584","journal-title":"Antioxidants (Basel)"},{"key":"ref100","doi-asserted-by":"publisher","DOI":"10.3390\/antiox14040492","article-title":"Advanced glycation end products in disease development and potential interventions","volume":"14","author":"Zhang Y","year":"2025","unstructured":"Zhang Y, Zhang Z, Tu C, Chen X, He R. Advanced glycation end products in disease development and potential interventions. Antioxidants (Basel). 2025, 14:492. 10.3390\/antiox14040492","journal-title":"Antioxidants (Basel)"},{"key":"ref101","doi-asserted-by":"publisher","DOI":"10.1002\/syn.22188","article-title":"Antinociceptive activity of the novel RAGE inhibitor, papaverine, in a mouse model of chronic inflammatory pain","volume":"75","author":"Yoshizawa K","year":"2021","unstructured":"Yoshizawa K, Takeuchi K, Nakamura T, et al.. Antinociceptive activity of the novel RAGE inhibitor, papaverine, in a mouse model of chronic inflammatory pain. Synapse. 2021, 75:e22188. 10.1002\/syn.22188","journal-title":"Synapse"},{"key":"ref102","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22136904","article-title":"Molecular characteristics of RAGE and advances in small-molecule inhibitors","volume":"22","author":"Kim HJ","year":"2021","unstructured":"Kim HJ, Jeong MS, Jang SB. Molecular characteristics of RAGE and advances in small-molecule inhibitors. Int J Mol Sci. 2021, 22:6904. 10.3390\/ijms22136904","journal-title":"Int J Mol Sci"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/498565-advanced-glycation-end-products-and-genetic-polymorphism-in-the-pathogenesis-of-microvascular-complications-in-type-2-diabetes-mellitus-a-narrative-review","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,30]],"date-time":"2026-05-30T17:45:13Z","timestamp":1780163113000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/498565-advanced-glycation-end-products-and-genetic-polymorphism-in-the-pathogenesis-of-microvascular-complications-in-type-2-diabetes-mellitus-a-narrative-review"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,30]]},"references-count":102,"URL":"https:\/\/doi.org\/10.7759\/cureus.109935","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5,30]]}}}